atenolol has been researched along with abanoquil in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Elliott, HL; Howie, CA; Reid, JL; Schafers, RF | 1 |
| Harron, DW; Shanks, RG; Uprichard, AG; Wilson, R | 1 |
1 trial(s) available for atenolol and abanoquil
| Article | Year |
|---|---|
Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: I. Effects on blood pressure, heart rate and pressor responsiveness in normotensive subjects.
Topics: Adrenergic alpha-Antagonists; Adult; Aminoquinolines; Atenolol; Blood Pressure; Double-Blind Method; Heart Rate; Humans; Injections, Intravenous; Male; Phenylephrine; Tetrahydroisoquinolines | 1991 |
2 other study(ies) available for atenolol and abanoquil
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Effects of the myocardial-selective alpha 1-adrenoceptor antagonist UK-52046 and atenolol, alone and in combination, on experimental cardiac arrhythmias in dogs.
Topics: Adrenergic alpha-Antagonists; Aminoquinolines; Animals; Arrhythmias, Cardiac; Atenolol; Coronary Vessels; Dogs; Drug Therapy, Combination; Electrophysiology; Epinephrine; Female; Halothane; Hemodynamics; Ligation; Male; Ouabain; Tetrahydroisoquinolines | 1988 |